What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion
Year of publication: |
2011-05
|
---|---|
Authors: | Moreno-Torres, Ivan |
Institutions: | Xarxa de Referència en Economia Aplicada (XREAP) |
Subject: | Pharmaceutical industry | Statin drugs | Competition | Regulation |
Extent: | application/pdf |
---|---|
Series: | |
Type of publication: | Book / Working Paper |
Notes: | Number XREAP2011-02 74 pages |
Classification: | I11 - Analysis of Health Care Markets ; I18 - Government Policy; Regulation; Public Health ; L13 - Oligopoly and Other Imperfect Markets ; L65 - Chemicals; Rubber; Drugs; Biotechnology |
Source: |
-
Generic drugs in Spain: price competition vs. moral hazard
Moreno-Torres, Ivan, (2011)
-
Generic Drugs in Spain : Price Competition versus Moral Hazard
Moreno-Torres, Iván, (2011)
-
Moreno-Torres, Iván, (2011)
- More ...
-
Generic drugs in Spain: price competition vs. moral hazard
Moreno-Torres, Ivan, (2011)
-
Impact of Pharmaceutical Prior Authorisation Policies: A Systematic Review of the Literature
Puig-Junoy, Jaume, (2007)
-
Solé-Auró, Aïda, (2009)
- More ...